BMY

The Insiders Fund Not So Daily Podcast | Bargain Basement Week

Insider Buying Week 05-09-25 Bargain Basement Week

by

  Finally, a busy week. I can’t extrapolate anything about the general market from these buys, but it’s clear that some insiders are sniffing out bargains. It would be nice to see an insider buying on good news but that’s not what it is this week. It’s more bargain basement stuff. Patience may be needed though as I doubt, we’ve seen the last of volatility. Let’s get into it. Listen to the podcast here Follow us on Twitter for real-time commentary and insider buying alerts at https://twitter.com/theinsidersfund  If you are a QUALIFIED INVESTOR and are interested in learning how you can be … Read more

Insider Buying Week 05-02-25 Record Run for the Bulls

by

Every bear market since 2001 has only ended with a plethora of insider buying.  I’m waiting, waiting, and waiting without any insider buying to speak of. There is not much selling either. Just keep in mind that bear markets don’t go straight down.  Who’s saying we are in one anyway? Maybe it’s just a slow-motion train wreck that every earnings webcast is riddled with uncertainty and lowered earnings expectations. Name: Joseph P. Adams Jr. Position: CEO and Chairman Transaction Date: 05-02-2025  Shares Bought: 3,000 shares an Average Price Paid of $94.54 for Cost: $283,620 Name: David Moreno Position: Chief Operating … Read more

Insider Buying Week 11-24-23 Are Investors the Turkey this Thanksgiving?

by

Trying to read the tea leaves and glean some information from insider buying patterns is seldom obvious.  Directors are generally required to own a percentage of their board compensation in the company’s equity.  Generally is the right word because this is not a requirement at every company.  Investors viewing this information have to weigh it against past purchases, if any, actual board stock ownership requirements, the relative size of the purchase, and, of course, the recent price history.  Are they buying near the highs or, more typically, purchasing shares at recent lows in price? Insiders tend to be value buyers, … Read more

”t forget the Covid-19 test kit $QDEL Insider Buying Week of 6-19-20

by

These are the insider buys that matter for last week. For real time insider alerts subscribe to our Twitter at https://twitter.com/theinsidersfund.  When insiders buy, stocks make knee jerk moves up. The best time period to make bank is the next three days, perhaps five and then the prior trend sets in.  Follow us on Twitter for the names we take an interest in. This week’s top movers are Camping World Holdings up 27.03% and Quidel, up 29.88% The average 3 day gain was 5.25% and holding just three days longer pushed it to 8.04%.  If there is no 5 day … Read more

U.S. Stocks Have Now Fallen For 5 Weeks In A Row but Some Insiders are Buying

by

The market gets scarier by the day.  Wealthy individuals pulled their money out at record rates not seen in seven years. Black swans seem to be showing up in multiple corners of the world, China trade war, Iran real war, just to mention a few. None the less that didn’t stop a few insiders with conviction loading up on their company’s stock. In fact, it’s the most buying we have seen in some time. We highlight those over $200,000 in this report.

Insider Selling Swamps Buying – Week Ending in May 4-2018

by

$DDR,$RDN,$FB,$GRMN,$ORCL,$MA,$NYT,$DOCU,$BMN,$PYPL,$CRM,$MASI,$ALXN In this report, we examine stocks that C-level officers and directors bought and sold ending the week of May 4, 2018. Insiders sell stock for many reasons, but they generally buy for just one – to make money.  As a standard, we only look at material amounts of money, $100 thousand or more, as anything less could just be window dressing. The bar is different with selling, because the natural state of management is to be sellers. This is because most companies provide significant amounts of management compensation packages as stock. Therefore, with selling, we analyze for unusual patterns, such … Read more

Cure Lung Cancer Now $BMY Bristol-Myers Squibb (BMY) Could Be Worth $59-$75 In Takeout W/O CM-227 – Goldman

by

Bristol-Myers Squibb (BMY) Could Be Worth $59-$75 In Takeout W/O CM-227 – GoldmanArticleGoldman Sachs maintained a Buy rating on Bristol-Myers Squibb Co. (NYSE: BMY) with a price target of $63.00.Analyst Jami Rubin says the stock could be worth $64-$74 per share depending on the varying degrees of success of CM-227. The analyst also notes that in a takeout scenario the stock could be worth $59-$75 per share with no value for CM-277. Source: Bristol-Myers Squibb (BMY) Could Be Worth $59-$75 In Takeout W/O CM-227 – Goldman   We believe CM-227 works so what is the price then?

What really happened today

by

Once the dust settles, pundits and analysts will begin to start calculating what we’ve been telling you all along.  Many, many blue chip stocks are dirt cheap based on discounted cash flow analysis with the risk free rate of 2 %or even 3% on the 10 year treasury.  Stay away from cyclicals and invest in the highest credit quality stocks like Coke, McDonald’s, Verizon, JP Morgan, BP, Bristol Myers, Kellogg, Microsoft etc.  These stocks are all way undervalued.  The reason the Bernanke shot his bazooka today is that he doesn’t want to go down as the Fed Reserve Chairman that … Read more